2014
DOI: 10.1586/14789450.2014.939634
|View full text |Cite
|
Sign up to set email alerts
|

Towards developing biomarkers for glioblastoma multiforme: a proteomics view

Abstract: Glioblastoma multiforme (GBM) is one of the most aggressive and lethal forms of the primary brain tumors. With predominance of tumor heterogeneity and emergence of new subtypes, new approaches are needed to develop tissue-based markers for tumor typing or circulatory markers to serve as blood-based assays. Multi-omics data integration for GBM tissues would offer new insights on the molecular view of GBM pathogenesis useful to identify biomarker panels. On the other hand, mapping differentially expressed tissue… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
27
0
1

Year Published

2015
2015
2019
2019

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 34 publications
(29 citation statements)
references
References 106 publications
1
27
0
1
Order By: Relevance
“…These observations may guide further explorations of the complexities associated with this emission, including the composition of EGFRvIII containing oncosomes (63), associated biomarkers (64,65), as well as potential for a broader biological effect resulting from interactions between EGFRvIII-driven EVs, tumor microenvironment and recipient cells (12,66).…”
Section: Discussionmentioning
confidence: 99%
“…These observations may guide further explorations of the complexities associated with this emission, including the composition of EGFRvIII containing oncosomes (63), associated biomarkers (64,65), as well as potential for a broader biological effect resulting from interactions between EGFRvIII-driven EVs, tumor microenvironment and recipient cells (12,66).…”
Section: Discussionmentioning
confidence: 99%
“…Glioblastoma multiforme (GBM), one of the most invasive and fatal brain tumours that develops from glial cells, can severely affects the central nervous system and general health [1]. The percent 5-year surviving rate was estimated to be 33.2% between 2008 and 2014 according to statistics from the Surveillance, Epidemiology and End Results (SEER) database and the Centers for Disease Control and Prevention's National Center for Health Statistics (https://seer.cancer.gov/ csr/1975_2015/).…”
Section: Introductionmentioning
confidence: 99%
“…Research on exosomes and other secreted membrane vesicles has expanded in the last decade due to their putative role in therapeutics (27), disease pathogenesis (28) and biomarker discovery (29, 30). These vesicles should be precisely characterized biophysically prior to investigating their role as intercellular messengers, biomarkers or therapeutic tools.…”
Section: Introductionmentioning
confidence: 99%